NVIDIA (NVDA) PT Raised to $132 at UBS Following 4Q Report

Go back to NVIDIA (NVDA) PT Raised to $132 at UBS Following 4Q Report

NVIDIA (NVDA) PT Raised to $130 at Canaccord Genuity Following 4Q

February 10, 2017 10:01 AM EST

Canaccord Genuity raised its price target on NVIDIA (NASDAQ: NVDA) to $130.00 (from $120.00) while maintaining a Buy rating. NVDA reported record revenue of $2.17B,
above $2.10B estimates and up 55% Y/Y. Non-GAAP EPS of $1.13 jumped past
consensus estimates of $0.98.

Analyst Matthew Ramsay commented, "NVIDIA reported another strong quarter for Q4/F'17 above our/consensus expectations with record revenue,... More

NVIDIA (NVDA) PT Raised to $90 at Stifel; "Record Revenue" Across Platforms

February 10, 2017 9:34 AM EST

Stifel analyst Kevin Cassidy reiterates Hold rating and raises price target on NVIDIA Corp. (NASDAQ: NVDA) to $90 (from $76), as the company produced 2016 fiscal fourth quarter revenue and EPS figures well above consensus, recording "record revenue" in each target platform.

Cassidy notes,... More

NVIDIA (NVDA) PT Raised to $100 at Instinet; Datacenter Main Driver in 4Q

February 10, 2017 6:54 AM EST

Instinet analyst Romit Shah reiterates Buy rating and increases price target on NVIDIA Corp. (NASDAQ: NVDA) to $100 (from $80), citing continued strength in Datacenter business, as the company delivered 2016 fourth quarter results above estimates.

Shah comments, "F4Q Beat on Revenue and... More

NVIDIA (NVDA) PT Raised to $140 at Jefferies Following 7th Consecutive Beat

February 10, 2017 6:47 AM EST

Jefferies raised its price target on NVIDIA (NASDAQ: NVDA) to $140.00 (from $125.00) while maintaining a Buy rating.

Analyst Mark Lipacis commented, "NVDA posted its 7th consecutive beat, and while YoY rev growth of 55% likely marks 2nd derivative peak, the 200% growth in its Datacenter... More

Needham & Company Reiterates Buy Rating on NVIDIA (NVDA) on Data Center Business

February 10, 2017 5:56 AM EST

Needham & Company analyst Rajvindra Gill reaffirms Buy rating and $120 price target on NVIDIA Corp. (NASDAQ: NVDA), noting strength in the Data Center business, as investors should remain buyers of the company, despite potential gaming business slowdown.

Gill comments, "NVIDIA delivered another stellar... More

Options expected to have Increasing volume: NVDA CERN YELP INFN COLM EXPE TRVG AGU

February 10, 2017 5:37 AM EST

Options expected to have Increasing volume: NVDA CERN YELP INFN COLM EXPE TRVG AGU

... More

NVIDIA (NVDA) PT Raised to $130 at RBC Capital

February 10, 2017 4:23 AM EST

RBC Capital raised its price target on NVIDIA (NASDAQ: NVDA) to $130.00 (from $124.00) while maintaining a Outperform rating.

Analyst Mitch Steves comments "Nvidia reported another solid quarter despite increasingly high expectations due to Data Center growth, sustained Gaming trends and higher than expected gross... More

NVIDIA (NVDA) PT Raised to $130 at Mizuho Securities

February 10, 2017 4:22 AM EST

Mizuho Securities raised its price target on NVIDIA (NASDAQ: NVDA) to $130.00 (from $115.00) while maintaining a Buy rating.

Analyst Vijay Rakesh comments "NVDA reported JanQ GAAP rev/EPS of $2.2B/$0.99, well above consensus of $2.1B/$0.83. NVDA noted strength in data center and gaming... More

After-Hours Stock Movers 02/09: (INFN) (ATVI) (SWIR) Higher; (RSYS) (TCON) (YELP) Lower (more...)

February 9, 2017 6:31 PM EST

Today's After-Hours Movers

Radisys Corp (NASDAQ: RSYS) 15% LOWER; reported Q4 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $40.6 million versus the consensus estimate of $42.06 million.

TRACON Pharmaceuticals (NASDAQ: TCON) 12.4% LOWER; reported top-line results from a randomized Phase 2 clinical trial of TRC105 in recurrent glioblastoma (GBM) funded and conducted by the Clinical Therapy Evaluation Program (CTEP) of the National Cancer Institute (NCI). In the trial, TRC105 combined with Avastin® (bevacizumab) was... More

NVIDIA (NVDA) Tops Q4 EPS by 30c as Revenues Surge 55%

February 9, 2017 4:20 PM EST

NVIDIA (NASDAQ: NVDA) reported Q4 EPS of $1.13, $0.30 better than the analyst estimate of $0.83. Revenue for the quarter came in at $2.17 billion versus the consensus estimate of $2.11 billion.

Record quarterly revenue of $2.17 billion, up 55 percent from a year agoRecord full-year revenue of $6.91 billion, up 38 percent from a year agoRecord quarterly GAAP gross margin at 60.0 percent, non-GAAP gross margin at 60.2 percentGPU computing platform continues to power gains across full product... More

NVIDIA (NVDA) EPS May Be a 'Sell the News' Kind of Print - Odeon

February 9, 2017 2:21 PM EST

Odeon's Jahanara Nissar weighs in on NVIDIA (NASDAQ: NVDA) into tonight's print. She sees it as a 'sell the news' kind of a print.

Nissar commented, "Everyone expects a beat and a raise but what I found curious is that... More

NVIDIA (NVDA) call put ratio 1 to 1 as shares near record high into Q4

February 9, 2017 12:40 PM EST

NVIDIA (NVDA) February weekly call option implied volatility is at 189, February is at 82, March is at 61: compared to its 52-week range of 27 to 68 into the expected release of Q4.

... More

Stocks with call price movement; NVDA AMD

February 9, 2017 10:16 AM EST

RT Options Scanner shows: NVIDIA (NASDAQ: NVDA) June 145 call option implied volatility increased 2% to 49, Advanced Micro Devices (NASDAQ: AMD) April 17 call option implied volatility increased 2% to 60

... More

Needham & Company Reiterates Buy Rating, $120 PT on NVIDIA (NVDA); Buy Into Print

February 9, 2017 7:17 AM EST

Needham & Company analyst Rajvindra Gill reiterates Buy rating and $120 price target on NVIDIA Corp. (NASDAQ: NVDA), suggesting that the company is at the forefront of the Intelligence Industrial Revolution.

Gill comments, "We upgraded NVDA to Buy (11/14/16), because we saw it as one of the... More

NVIDIA (NVDA) call put ratio 1 to 1 as shares near record high into Q4

February 9, 2017 7:10 AM EST

NVIDIA (NASDAQ: NVDA) February weekly call option implied volatility is at 149, February is at 84, March is at 67: compared to its 52-week range of 27 to 68 into the expected release of Q4.

... More

NVIDIA (NVDA) February weekly call option implied volatility increases into Q4

February 8, 2017 2:40 PM EST

NVIDIA (NASDAQ: NVDA) February weekly call option implied volatility is at 145, February is at 82, March is at 54: compared to its 52-week range of 27 to 68 into the expected release of Q4 results.

... More

Stocks with call price movement; NVDA TEVA

February 8, 2017 10:08 AM EST

NVIDIA (NASDAQ: NVDA) April 145 call option implied volatility increased 2% to 47, Teva Pharma (NYSE: TEVA) June 37.50 call option implied volatility increased 2% to 34

... More